Clinical trials
Phase 3 Liver Diseases trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Terminated | 3 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| Abbott | 1 |
| GC Biopharma Corp | 1 |
| GlaxoSmithKline | 1 |
| Imunon | 1 |
| Yonsei University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 7 |
| Digestive System Diseases | 4 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Adenocarcinoma | 2 |
| Carcinoma | 2 |
| Carcinoma, Hepatocellular | 2 |
| Digestive System Neoplasms | 2 |
| Fatty Liver | 2 |
| Fibrosis | 2 |
| Hepatitis B | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.